173 related articles for article (PubMed ID: 31680143)
1. Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Keam B; Kang CK; Jun KI; Moon SM; Suh KJ; Lee DW; Ock CY; Kim M; Choi Y; Lim Y; Lee KH; Kim SH; Kim TM; Kim TY; Oh DY; Kim DW; Im SA; Lee JS; Kim ES; Kim HB; Kim NJ; Kim YJ; Park WB; Oh MD
Clin Infect Dis; 2020 Jul; 71(2):422-425. PubMed ID: 31680143
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of influenza vaccine in patients with lung cancer receiving immune checkpoint inhibitors: A single-center prospective cohort study.
Nakashima K; Homma Y; Taniguchi J; Kubota N; Otsuki A; Ito H; Otsuka Y; Kondo K; Ohfuji S; Fukushima W; Hirota Y
J Infect Chemother; 2023 Nov; 29(11):1038-1045. PubMed ID: 37481070
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review.
Spagnolo F; Boutros A; Croce E; Cecchi F; Arecco L; Tanda E; Pronzato P; Lambertini M
Eur J Clin Invest; 2021 Jul; 51(7):e13604. PubMed ID: 34021591
[TBL] [Abstract][Full Text] [Related]
4. Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors.
Kang CK; Kim HR; Song KH; Keam B; Choi SJ; Choe PG; Kim ES; Kim NJ; Kim YJ; Park WB; Kim HB; Oh MD
J Infect Dis; 2020 Nov; 222(11):1902-1909. PubMed ID: 32479600
[TBL] [Abstract][Full Text] [Related]
5. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).
Bersanelli M; Giannarelli D; De Giorgi U; Pignata S; Di Maio M; Clemente A; Verzoni E; Giusti R; Di Napoli M; Aprile G; Ermacora P; Catino A; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Rossi E; Grossi F; Casadei C; Ficorella C; Montesarchio V; Verderame F; Rizzo M; Guaitoli G; Fratino L; Accettura C; Mencoboni M; Zustovich F; Baldessari C; Cinieri S; Camerini A; Laera L; Sorarù M; Zucali PA; Guadalupi V; Leonardi F; Tiseo M; Tognetto M; Di Costanzo F; Pinto C; Negrini G; Russo A; Migliorino MR; Filetti M; Buti S;
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016723
[TBL] [Abstract][Full Text] [Related]
6. Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial.
Jamshed S; Walsh EE; Dimitroff LJ; Santelli JS; Falsey AR
Vaccine; 2016 Jan; 34(5):630-635. PubMed ID: 26721330
[TBL] [Abstract][Full Text] [Related]
7. The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data.
Grima AA; Kwong JC; Richard L; Reid J; Raphael J; Basta NE; Carignan A; Top KA; Brousseau N; Blanchette PS; Sundaram ME;
Vaccine; 2024 Mar; 42(7):1498-1505. PubMed ID: 38341288
[TBL] [Abstract][Full Text] [Related]
8. Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Chong CR; Park VJ; Cohen B; Postow MA; Wolchok JD; Kamboj M
Clin Infect Dis; 2020 Jan; 70(2):193-199. PubMed ID: 30874791
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
Shirai S; Hara M; Sakata Y; Tsuruoka N; Yamamoto K; Shimoda R; Gomi Y; Yoshii H; Fujimoto K; Iwakiri R
Inflamm Bowel Dis; 2018 Apr; 24(5):1082-1091. PubMed ID: 29538682
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Influenza Vaccination in Patients With Cancer.
Waqar SN; Boehmer L; Morgensztern D; Wang-Gillam A; Sorscher S; Lawrence S; Gao F; Guebert K; Williams K; Govindan R
Am J Clin Oncol; 2018 Mar; 41(3):248-253. PubMed ID: 26669741
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.
Awadalla M; Golden DLA; Mahmood SS; Alvi RM; Mercaldo ND; Hassan MZO; Banerji D; Rokicki A; Mulligan C; Murphy SPT; Jones-O'Connor M; Cohen JV; Heinzerling LM; Armanious M; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Rizvi MA; Sahni G; Lyon AR; Tocchetti CG; Mercurio V; Thuny F; Ederhy S; Mahmoudi M; Lawrence DP; Groarke JD; Nohria A; Fradley MG; Reynolds KL; Neilan TG
J Immunother Cancer; 2019 Feb; 7(1):53. PubMed ID: 30795818
[TBL] [Abstract][Full Text] [Related]
12. Vaccination and Immune Checkpoint Inhibitors: Does Vaccination Increase the Risk of Immune-related Adverse Events? A Systematic Review of Literature.
Desage AL; Bouleftour W; Rivoirard R; Magne N; Collard O; Fournel P; Tissot C
Am J Clin Oncol; 2021 Mar; 44(3):109-113. PubMed ID: 33350679
[TBL] [Abstract][Full Text] [Related]
13. State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough.
Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Pignata S; Banna GL
Crit Rev Oncol Hematol; 2019 Jul; 139():87-90. PubMed ID: 31112887
[TBL] [Abstract][Full Text] [Related]
14. Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients.
Bersanelli M; Scala S; Affanni P; Veronesi L; Colucci ME; Banna GL; Cortellini A; Liotta F
Immunotherapy; 2020 Feb; 12(2):105-110. PubMed ID: 32046555
[No Abstract] [Full Text] [Related]
15. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
Keam B; Kim MK; Choi Y; Choi SJ; Choe PG; Lee KH; Kim TM; Kim TY; Oh DY; Kim DW; Im SA; Kim NJ; Heo DS; Park WB; Oh MD
Cancer; 2017 Mar; 123(5):841-848. PubMed ID: 27997703
[TBL] [Abstract][Full Text] [Related]
16. Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors.
Groeneveld GH; Wijn DH; Vollaard AM
Clin Infect Dis; 2020 Mar; 70(7):1519. PubMed ID: 31210266
[No Abstract] [Full Text] [Related]
17. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.
Woerner A; Sauvain MJ; Aebi C; Otth M; Bolt IB
Hum Vaccin; 2011 Dec; 7(12):1293-8. PubMed ID: 22185812
[TBL] [Abstract][Full Text] [Related]
18. Influenza Vaccination in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Tsiakos K; Kyriakoulis KG; Kollias A; Kyriakoulis IG; Poulakou G; Syrigos K
J Immunother; 2022 Jul-Aug 01; 45(6):291-298. PubMed ID: 35639000
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.
Soedjatmiko S; Medise BE; Gunardi H; Sekartini R; Satari HI; Hadinegoro SR; Bachtiar NS; Sari RM
Vaccine; 2018 Apr; 36(16):2126-2132. PubMed ID: 29551225
[TBL] [Abstract][Full Text] [Related]
20. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
